CASD1
N-acetylneuraminate (7)9-O-acetyltransferase
Also known as: C7orf12, CASD1_HUMAN, FLJ21213, FLJ21879
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96PB1
- Gene
- CASD1
- Ensembl
- ENSG00000127995
- Chromosome
- 7
- Canonical length
- 797 aa
- Protein class
- Enzymes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Enables N-acetylneuraminate 9-O-acetyltransferase activity. Involved in carbohydrate metabolic process. Located in Golgi membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
797 residues, UniProt reviewed canonical sequence.
>Q96PB1|CASD1
1 MAALAYNLGK REINHYFSVR SAKVLALVAV LLLAACHLAS RRYRGNDSCE YLLSSGRFLG
61 EKVWQPHSCM MHKYKISEAK NCLVDKHIAF IGDSRIRQLF YSFVKIINPQ FKEEGNKHEN
121 IPFEDKTASV KVDFLWHPEV NGSMKQCIKV WTEDSIAKPH VIVAGAATWS IKIHNGSSEA
181 LSQYKMNITS IAPLLEKLAK TSDVYWVLQD PVYEDLLSEN RKMITNEKID AYNEAAVSIL
241 NSSTRNSKSN VKMFSVSKLI AQETIMESLD GLHLPESSRE TTAMILMNVY CNKILKPVDG
301 SCCQPRPPVT LIQKLAACFF TLSIIGYLIF YIIHRNAHRK NKPCTDLESG EEKKNIINTP
361 VSSLEILLQS FCKLGLIMAY FYMCDRANLF MKENKFYTHS SFFIPIIYIL VLGVFYNENT
421 KETKVLNREQ TDEWKGWMQL VILIYHISGA STFLPVYMHI RVLVAAYLFQ TGYGHFSYFW
481 IKGDFGIYRV CQVLFRLNFL VVVLCIVMDR PYQFYYFVPL VTVWFMVIYV TLALWPQIIQ
541 KKANGNCFWH FGLLLKLGFL LLFICFLAYS QGAFEKIFSL WPLSKCFELK GNVYEWWFRW
601 RLDRYVVFHG MLFAFIYLAL QKRQILSEGK GEPLFSNKIS NFLLFISVVS FLTYSIWASS
661 CKNKAECNEL HPSVSVVQIL AFILIRNIPG YARSVYSSFF AWFGKISLEL FICQYHIWLA
721 ADTRGILVLI PGNPMLNIIV STFIFVCVAH EISQITNDLA QIIIPKDNSS LLKRLACIAA
781 FFCGLLILSS IQDKSKHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CASD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 15
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 24 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 24 nTPM
- cerebral cortex: 22 nTPM
- retina: 20 nTPM
- salivary gland: 19 nTPM
- tongue: 18 nTPM
- rectum: 18 nTPM
Single-cell type
- corticotrophs: 252 nCPM
- gonadotrophs: 215 nCPM
- thyrotrophs: 201 nCPM
- lactotrophs: 200 nCPM
- adrenal cortex cells: 183 nCPM
- sertoli cells: 175 nCPM
Immune cell
- MAIT T-cell: 1.6 nTPM
- memory CD4 T-cell: 0.9 nTPM
- naive CD4 T-cell: 0.9 nTPM
- memory CD8 T-cell: 0.8 nTPM
- naive CD8 T-cell: 0.7 nTPM
- gdT-cell: 0.6 nTPM
Brain region
- hypothalamus: 48 nTPM
- hippocampal formation: 43 nTPM
- basal ganglia: 40 nTPM
- white matter: 40 nTPM
- pons: 39 nTPM
- cerebral cortex: 38 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.44
- gnomAD pLI
- 0.04
- gnomAD missense Z
- 1.96
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- N-acetylneuraminate 9-O-acetyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cyclin-like superfamily
- NXPE, C-terminal
- NXPE family member 4-like, C-terminal domain
- Cas1p, 10 TM acyl transferase domain
- 10 TM Acyl Transferase domain found in Cas1p
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CASD1 as an antibody target. Whether an autoantibody or antibody against CASD1 could matter depends on whether native CASD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CASD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CASD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...